| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/24/2008 | WO2007139921A3 N-oxides of kappa opioid receptor peptides |
| 01/24/2008 | US20080021109 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/24/2008 | US20080021102 Method for the Management of Incontinence |
| 01/24/2008 | US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080021021 Preventive And/Or Remedy For Lower Urinary Tract Diseases Containing Ep4 Agonist |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021002 Vitamin d compounds used to stabilize kidney transplants |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | DE102006033140A1 Aminoindazolharnstoffderivate Aminoindazolharnstoffderivate |
| 01/23/2008 | EP1880995A1 Method for producing indole derivative having piperidine ring |
| 01/23/2008 | EP1880994A1 Crystal of indole derivative having piperidine ring and process for production thereof |
| 01/23/2008 | EP1880719A2 Composition for prophylaxis or treatment of urinary system infection and method thereof |
| 01/23/2008 | EP1880213A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 01/23/2008 | EP1879610A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases |
| 01/23/2008 | EP1879578A2 Methods and compositions for the treatment of urinary incontinence |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1330451B1 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1246903B1 Reconstructing organs from decellularized biomaterial scaffold |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | CN101111254A Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts |
| 01/23/2008 | CN101111240A Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperp |
| 01/23/2008 | CN101108878A Glp-1 analogues |
| 01/23/2008 | CN101108202A Flush fluid for vesica urinaria extracted from pure plants |
| 01/23/2008 | CN101108182A Oral solution |
| 01/23/2008 | CN101108176A Treating smooth muscle hyperactivity with (R)-oxybutynin and (R)- desethyloxybutynin |
| 01/23/2008 | CN101108174A Pharmaceutical composition having active ingredient of tamsulosin hydrochloride and finasteride |
| 01/23/2008 | CN101107995A Traditional Chinese medicine health care beverage bag |
| 01/23/2008 | CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same |
| 01/23/2008 | CN100363362C Thiazole derivatives as NPY receptor antagonists |
| 01/23/2008 | CN100362990C Fibrauretine-amino acid fluid for transfusion and its production process |
| 01/22/2008 | US7320984 Administering 4,5 alpha -epoxy-6 beta -(3,4-dihydro-2H-benzo[1,4]thiazino)-3-methoxy-17-methyl-morphinan; for urinary frequency, therapeutic or prophylactic effect and of which side effects are improved |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320963 Methods and compositions for delivery of pharmaceutical agents |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2216150C Epithelial adhesive lactobacilli |
| 01/17/2008 | WO2008007711A1 Sart3-derived peptide useful in cancer vaccine therapy for hla-a3 supertype allele-positive prostate cancer patient |
| 01/17/2008 | WO2008007664A1 Bicyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008007661A1 Tricyclic heterocyclic compound and use thereof |
| 01/17/2008 | WO2008006895A2 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta t cell activators |
| 01/17/2008 | WO2008006795A2 Indole compounds |
| 01/17/2008 | WO2008006790A1 Indole compounds |
| 01/17/2008 | WO2008006480A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | WO2004106935A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 103 (gpr103) |
| 01/17/2008 | US20080015242 Use of N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydroxyethyl]phenyl]methanesulfonamide or salt for treating diabetes, obesity, hyperlipidemia and urinary incontinence; drug interaction side effect reduction |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015176 such as dabigatran etexilate in children; congenital heart disease, shunt or catheter thrombosis, pulmonary embolism, stroke in pregnant girls; pediatrics |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015157 Novel Water-Soluble Prodrugs |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014238 Implantable medical devices comprising semi-crystalline poly(easter-amide) |
| 01/17/2008 | US20080014237 Sustained release compositions, process for producing the same and use thereof |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2658222A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using .gamma. .delta. t cell activators |
| 01/17/2008 | CA2657300A1 Biarylcarboxyarylamides as vanilloid-1 receptor modulators |
| 01/16/2008 | EP1878734A1 Novel lactam compound |
| 01/16/2008 | EP1878732A1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878719A1 Crystal polymorph of hydroxynorephedrin derivative hydrochloride |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1878440A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds |
| 01/16/2008 | EP1878436A1 Method of regenerating or repairing damaged tissue by using adrenomedulin |
| 01/16/2008 | EP1878430A1 Peritoneal dialysis fluid |
| 01/16/2008 | EP1877367A1 Acetylene derivatives |
| 01/16/2008 | EP1429754B1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 01/16/2008 | EP1204626B1 Ether compounds, compositions, and uses thereof |
| 01/16/2008 | CN101104044A Traditional Chinese medicine formula for treating urinary infection |
| 01/16/2008 | CN101104024A Traditional Chinese medicine composition for treating benign prostate hyperplasia and application thereof |
| 01/16/2008 | CN101103961A Oral mixed suspension preparation |
| 01/16/2008 | CN100362008C Barbat skullcap general flavone preparation method and quality control method |
| 01/16/2008 | CN100361665C Compositions and methods for treatment of mitochondrial diseases |
| 01/15/2008 | US7319033 Transcritpional control; prostate glands; anticancer agents |
| 01/15/2008 | CA2210684C Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 01/10/2008 | WO2008004598A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 01/10/2008 | WO2008003245A1 The use of rosmarinic acid in the manufacture of medicaments for treating or preventing hepatic and renal diseases |
| 01/10/2008 | WO2008003141A1 Therapeutic compounds |
| 01/10/2008 | WO2007125088A3 Kidney-derived stem cell population, identification and therapeutic use |
| 01/10/2008 | WO2007117549A3 Co-administration of adenosine a1 receptor antagonists and anticonvulsants |
| 01/10/2008 | US20080009538 Methods and compositions for the treatment of urinary incontinence |
| 01/10/2008 | US20080009536 Novel PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
| 01/10/2008 | US20080009518 5-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | CA2658060A1 Erythropoietin-producing organoid precursor, production method thereof, and method for treating erythropoietin-related disorder |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876167A1 Crystal polymorphism of 4 -{2-ý(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino¨ethoxy}-3-isopropyl-3 ,5 -dimethylbiphenylcarboxylic acid hydrochloride |